Arcturus Therapeutics Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Arcturus Therapeutics's estimated annual revenue is currently $15.7M per year.
- Arcturus Therapeutics received $3.0M in venture funding in May 2017.
- Arcturus Therapeutics's estimated revenue per employee is $155,000
- Arcturus Therapeutics's total funding is $88.2M.
- Arcturus Therapeutics has 101 Employees.
- Arcturus Therapeutics grew their employee count by 26% last year.
- Arcturus Therapeutics currently has 13 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Online Review||Pricing|
What Is Arcturus Therapeutics?
Arcturus Therapeutics is a preclinical drug delivery and nucleic acid medicines company. We are focused on developing novel technologies to build the next generation of safe, effective RNA and DNA medicines. We have proprietary technologies, validating partnerships, and an experienced team with deep expertise in delivery and nucleic acid-based therapeutics. Arcturus Therapeutics is presently recruiting outstanding candidates with experience in the field of RNA technologies and nanoparticle sciences. Only exceptional applicants need apply. Compensation and equity position is commensurate. Please email your resume to Careers@ArcturusRx.com, or visit https://arcturusrx.com/careers/keywords:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
Arcturus Therapeutics News
15, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (“Arcturus Therapeutics”) (NASDAQ: ARCT), a leading messenger RNA ...
SAN DIEGO, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (“Arcturus Therapeutics”) (ARCT), a leading ...
CFO of Arcturus Therapeutics Holdings Inc (30-Year Financial, Insider Trades) Andy Sassine (insider trades) bought 10,000 shares of ARCT on ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding||Online Review||Pricing|
Arcturus Therapeutics Funding
|2017-05-31||$3.0M||Undisclosed||Cystic Fibrosis Foundation Therapeutics||Article|
Arcturus Therapeutics Executive Hires
|2013-10-29||Zachary A. Zimmerman||Chief Business Officer||Article|
|2018-02-13||Christine Esau||Vice President of Research and Development||Article|
|2018-08-29||Andrew Sassine||Interim Chief Financial Officer||Article|
Arcturus Therapeutics New Location/Offices
|2014-11-04||San Diego, CA||Article|